August 14, 2019
Weaponizing Biotech: How China’s Military Is Preparing for a ‘New Domain of Warfare’
Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement, and more.
We may be on the verge of a brave new world indeed. Today’s advances in biotechnology and genetic engineering have exciting applications in medicine — yet also alarming implications, including for military affairs. China’s national strategy of military-civil fusion (军民融合) has highlighted biology as a priority, and the People’s Liberation Army could be at the forefront of expanding and exploiting this knowledge.
The PLA’s keen interest is reflected in strategic writings and research that argue that advances in biology are contributing to changing the form or character (形态) of conflict. For example:
- In 2010’s War for Biological Dominance (制生权战争), Guo Jiwei (郭继卫), a professor with the Third Military Medical University, emphasizes the impact of biology on future warfare.
- In 2015, then-president of the Academy of Military Medical Sciences He Fuchu (贺福初) argued that biotechnology will become the new “strategic commanding heights” of national defense, from biomaterials to “brain control” weapons. Maj. Gen. He has since become the vice president of the Academy of Military Sciences, which leads China’s military science enterprise.
- Biology is among seven “new domains of warfare” discussed in a 2017 book by Zhang Shibo (张仕波), a retired general and former president of the National Defense University, who concludes: “Modern biotechnology development is gradually showing strong signs characteristic of an offensive capability,” including the possibility that “specific ethnic genetic attacks” (特定种族基因攻击) could be employed.
- The 2017 edition of Science of Military Strategy (战略学), a textbook published by the PLA’s National Defense University that is considered to be relatively authoritative, debuted a section about biology as a domain of military struggle, similarly mentioning the potential for new kinds of biological warfare to include “specific ethnic genetic attacks.”
Read the full article in Defense One.
More from CNAS
-
Germany’s Indo-Pacific Vision: A New Reckoning With China or More Strategic Drift?
Commentary
Berlin’s regional strategy tinkers around the edges of trade policy without risking the cost of a full-fledged strategic reckoning with China....
By Coby Goldberg
-
Designing a U.S. Digital Development Strategy
Commentary
The digital choices that U.S. allies and partners make today will play a critical role in shaping the future of U.S. national security....
By Siddharth Mohandas, Kristine Lee, Joshua Fitt & Coby Goldberg
-
Future of US-China Competition with Richard Fontaine
Podcast
CNAS CEO Richard Fontaine joins the Hopkins Podcast on Foreign Affairs from Johns Hopkins University to discuss the latest developments in U.S.-China relations.Listen to the f...
By Richard Fontaine
-
Local Interests, Chinese Ambitions, and an Intelligent American Response
Commentary
Review of Daniel Markey, China’s Western Horizon: Beijing and the New Geopolitics of Eurasia (New York: Oxford University Press, 2020). In his book China’s Western Horizon: Be...
By Emily Jin
